AIP Form 144 Notice: 19,060 Shares Planned Sale Worth $200,130
Rhea-AI Filing Summary
Arteris, Inc. reported a Form 144 notice showing an intended sale of 19,060 shares of its common stock by a holder using Morgan Stanley Smith Barney LLC as broker, with an aggregate market value of $200,130.00. The filing states the shares were acquired as Restricted Stock Units on 09/03/2024 and the planned approximate sale date is 10/02/2025 on NASDAQ. The issuer has 42,649,917 shares outstanding per the filing. The notice also lists multiple recent sales by the same person under a 10b5-1 plan and direct sales between 07/03/2025 and 09/09/2025, totaling tens of thousands of shares and several hundred thousand dollars in gross proceeds.
Positive
- Securities were acquired as Restricted Stock Units, indicating standard equity compensation rather than insider purchases
- Planned sale is modest relative to outstanding shares (19,060 vs 42,649,917 outstanding)
Negative
- Recent selling activity under a 10b5-1 plan and direct sales includes larger totals (e.g., 34,400 shares on 08/05/2025), which may reflect notable insider disposition
- Form 144 records multiple sales over the past months with aggregate gross proceeds in the hundreds of thousands of dollars
Insights
TL;DR: An insider intends to sell 19,060 RSU-derived shares worth $200,130; recent 10b5-1 and direct sales are listed.
The Form 144 shows the securities to be sold were acquired as Restricted Stock Units on 09/03/2024, indicating the holder is disposing of recently vested equity rather than long-held stock.
The filing records several sales executed under a 10b5-1 plan and one direct sale between 07/03/2025 and 09/09/2025, with individual gross proceeds reported (for example, $466,763.28 on 08/05/2025).